Delivery Order SPE2DB24D2105-SPE2DB25FAQHB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,834.50 to AmerisourceBergen Drug Corp for PROMACTA 12.5 mg tablets (30-count units) on August 13, 2025, with a completion date of September 4, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PROMACTA is a pharmaceutical treatment typically used for immune thrombocytopenia and other hematologic conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.63 to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. PROMACTA is an immunosuppressant medication commonly used to treat thrombocytopenia in patients...
- The Defense Logistics Agency awarded a delivery order valued at $13,333.47 to AmerisourceBergen Drug Corp for PROMACTA 25 MG Suspension packets (30-count units) on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. PROMACTA is a pharmaceutical treatment used primarily for immune...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,251.75 to AmerisourceBergen Drug Corp for the supply of PROMACTA 12.5 mg tablets in packages of 30 units. This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by October 6, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PROMACTA is a prescription medication used to treat thrombocytopenia, a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,251.75 on September 22, 2025, for the supply of PROMACTA 12.5 MG tablets in quantities of 30s. This firm fixed price delivery order, with an ultimate completion date of October 14, 2025, was competitively awarded without set-aside provisions. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $13,251.75 to AmerisourceBergen Drug Corp for the supply of PROMACTA 12.5 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for PROMACTA 50 mg tablets in packages of 30 units. This firm fixed-price delivery order, valued at $8,026.53, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by August 14, 2025. The award leverages AmerisourceBergen's established relationship as a critical pharmaceutical vendor within the federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of PROMACTA 12.5 mg tablets in quantities of 30 units, with a contract ceiling value of $4,417.24 and an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $12,029.63 and is scheduled for completion by July 16, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Promacta is a prescription...
- The Defense Logistics Agency awarded a $13,254.18 delivery order to AmerisourceBergen Drug Corp for PROMACTA 25 mg tablets (30-count units) on August 26, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQHBDelivery Order
The Defense Logistics Agency awarded a $8,834.50 delivery order to AmerisourceBergen Drug Corp for PROMACTA 12.5 mg tablets (30-count units) on September 25, 2025, with an ultimate completion date of October 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PROMACTA is an immunosuppressant medication commonly prescribed to treat thrombocytopenia, supporting the Department of Defense's pharmaceutical supply requirements for military healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates proven capability to meet defense healthcare supply needs through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 9/25/25 |